These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8929983)

  • 21. Altered neuropeptide Y concentrations in specific hypothalamic regions of obese (fa/fa) Zucker rats. Possible relationship to obesity and neuroendocrine disturbances.
    McKibbin PE; Cotton SJ; McMillan S; Holloway B; Mayers R; McCarthy HD; Williams G
    Diabetes; 1991 Nov; 40(11):1423-9. PubMed ID: 1657667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of estradiol on acute and recurrent insulin-induced hypoglycemia-associated patterns of arcuate neuropeptide Y, proopiomelanocortin, and cocaine- and amphetamine-related transcript gene expression in the ovariectomized rat.
    Nedungadi TP; Briski KP
    Neuroendocrinology; 2007; 86(4):270-6. PubMed ID: 17934251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lactation alters neuropeptide-Y and proopiomelanocortin gene expression in the arcuate nucleus of the rat.
    Smith MS
    Endocrinology; 1993 Sep; 133(3):1258-65. PubMed ID: 8365368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intragastric administration of evodiamine suppresses NPY and AgRP gene expression in the hypothalamus and decreases food intake in rats.
    Shi J; Yan J; Lei Q; Zhao J; Chen K; Yang D; Zhao X; Zhang Y
    Brain Res; 2009 Jan; 1247():71-8. PubMed ID: 18955035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin.
    Bergen HT; Mizuno TM; Taylor J; Mobbs CV
    Endocrinology; 1998 Nov; 139(11):4483-8. PubMed ID: 9794456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones.
    Bing C; King P; Pickavance L; Brown M; Ziegler D; Kaan E; Williams G
    Br J Pharmacol; 1999 May; 127(1):35-42. PubMed ID: 10369453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Young adult-specific hyperphagia in diabetic Goto-kakizaki rats is associated with leptin resistance and elevation of neuropeptide Y mRNA in the arcuate nucleus.
    Maekawa F; Fujiwara K; Kohno D; Kuramochi M; Kurita H; Yada T
    J Neuroendocrinol; 2006 Oct; 18(10):748-56. PubMed ID: 16965293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperphagia in cold-exposed rats is accompanied by decreased plasma leptin but unchanged hypothalamic NPY.
    Bing C; Frankish HM; Pickavance L; Wang Q; Hopkins DF; Stock MJ; Williams G
    Am J Physiol; 1998 Jan; 274(1):R62-8. PubMed ID: 9458899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor messenger RNA expression in rat hypothalamus as a function of genetic sex and estrogen dose.
    Lauber AH; Mobbs CV; Muramatsu M; Pfaff DW
    Endocrinology; 1991 Dec; 129(6):3180-6. PubMed ID: 1954897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone-releasing peptide-6 increases insulin-like growth factor-I mRNA levels and activates Akt in RCA-6 cells as a model of neuropeptide Y neurones.
    Frago LM; Pañeda C; Argente J; Chowen JA
    J Neuroendocrinol; 2005 Nov; 17(11):701-10. PubMed ID: 16218998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moderate long-term modulation of neuropeptide Y in hypothalamic arcuate nucleus induces energy balance alterations in adult rats.
    Sousa-Ferreira L; Garrido M; Nascimento-Ferreira I; Nobrega C; Santos-Carvalho A; Alvaro AR; Rosmaninho-Salgado J; Kaster M; Kügler S; de Almeida LP; Cavadas C
    PLoS One; 2011; 6(7):e22333. PubMed ID: 21799827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic administration of glucocorticoids directly upregulates prepro-neuropeptide Y and Y1-receptor mRNA levels in the arcuate nucleus of the rat.
    Larsen PJ; Jessop DS; Chowdrey HS; Lightman SL; Mikkelsen JD
    J Neuroendocrinol; 1994 Apr; 6(2):153-9. PubMed ID: 8049712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats.
    Dube MG; Xu B; Kalra PS; Sninsky CA; Kalra SP
    Brain Res; 1999 Jan; 816(1):38-46. PubMed ID: 9878684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypothalamic neuropeptide-Y gene expression increases before the onset of the ovarian steroid-induced luteinizing hormone surge.
    Sahu A; Crowley WR; Kalra SP
    Endocrinology; 1994 Mar; 134(3):1018-22. PubMed ID: 8119137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A selective sexually dimorphic response in the median eminence neuropeptide Y.
    Sahu A; Crowley WR; Kalra PS; Kalra SP
    Brain Res; 1992 Feb; 573(2):235-42. PubMed ID: 1504763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropeptide Y, the hypothalamus, and diabetes: insights into the central control of metabolism.
    Frankish HM; Dryden S; Hopkins D; Wang Q; Williams G
    Peptides; 1995; 16(4):757-71. PubMed ID: 7479313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation.
    Sanacora G; Kershaw M; Finkelstein JA; White JD
    Endocrinology; 1990 Aug; 127(2):730-7. PubMed ID: 2373052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion.
    Akabayashi A; Wahlestedt C; Alexander JT; Leibowitz SF
    Brain Res Mol Brain Res; 1994 Jan; 21(1-2):55-61. PubMed ID: 8164522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothalamic neuropeptide Y gene expression in rats on scheduled feeding regimen.
    Sahu A; White JD; Kalra PS; Kalra SP
    Brain Res Mol Brain Res; 1992 Sep; 15(1-2):15-8. PubMed ID: 1331661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice.
    Bina KG; Cincotta AH
    Neuroendocrinology; 2000 Jan; 71(1):68-78. PubMed ID: 10644901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.